Renaissance Technologies’s Novo Nordisk NVO Stock Holding History

Renaissance Technologies’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$125M	Buy	3,397,121 +213,443	+7%	+$10.1M	0.2%	108
2025 Q4	$162M	Buy	3,183,678 +301,682	+10%	+$15.4M	0.25%	82
2025 Q3	$160M	Sell	2,881,996 -2,054,800	-42%	-$120M	0.21%	90
2025 Q2	$341M	Sell	4,936,796 -1,884,600	-28%	-$128M	0.45%	30
2025 Q1	$474M	Sell	6,821,396 -1,491,600	-18%	-$123M	0.72%	11
2024 Q4	$715M	Buy	8,312,996 +123,681	+2%	+$13.4M	1.06%	3
2024 Q3	$975M	Sell	8,189,315 -976,059	-11%	-$130M	1.47%	2
2024 Q2	$1.31B	Sell	9,165,374 -1,620,700	-15%	-$215M	2.22%	1
2024 Q1	$1.38B	Sell	10,786,074 -3,063,261	-22%	-$365M	2.18%	1
2023 Q4	$1.43B	Sell	13,849,335 -2,380,141	-15%	-$235M	2.22%	1
2023 Q3	$1.48B	Sell	16,229,476 -2,512,500	-13%	-$221M	2.52%	1
2023 Q2	$1.52B	Sell	18,741,976 -2,862,600	-13%	-$234M	2.19%	1
2023 Q1	$1.72B	Sell	21,604,576 -3,604,000	-14%	-$256M	2.28%	1
2022 Q4	$1.71B	Sell	25,208,576 -5,409,166	-18%	-$317M	2.33%	1
2022 Q3	$1.53B	Sell	30,617,742 -4,441,600	-13%	-$238M	2.16%	1
2022 Q2	$1.95B	Sell	35,059,342 -1,708,600	-5%	-$94.8M	2.31%	1
2022 Q1	$2.04B	Sell	36,767,942 -1,465,800	-4%	-$75.2M	2.4%	1
2021 Q4	$2.14B	Sell	38,233,742 -5,047,600	-12%	-$273M	2.66%	1
2021 Q3	$2.08B	Sell	43,281,342 -5,080,800	-11%	-$246M	2.68%	1
2021 Q2	$2.03B	Sell	48,362,142 -1,331,200	-3%	-$51.6M	2.53%	1
2021 Q1	$1.68B	Sell	49,693,342 -3,989,000	-7%	-$142M	2.08%	1
2020 Q4	$1.87B	Sell	53,682,342 -2,560,120	-5%	-$88.5M	2.04%	1
2020 Q3	$1.95B	Sell	56,242,462 -1,177,200	-2%	-$39.2M	1.95%	2
2020 Q2	$1.88B	Buy	57,419,662 +1,699,210	+3%	+$54.2M	1.62%	2
2020 Q1	$1.68B	Buy	55,720,452 +3,286,400	+6%	+$97.9M	1.63%	2
2019 Q4	$1.52B	Buy	52,434,052 +2,860,620	+6%	+$79.2M	1.17%	5
2019 Q3	$1.28B	Buy	49,573,432 +4,529,600	+10%	+$115M	1.08%	5
2019 Q2	$1.15B	Buy	45,043,832 +2,354,000	+6%	+$58.2M	1.01%	3
2019 Q1	$1.12B	Buy	42,689,832 +1,200,690	+3%	+$29.5M	1.02%	2
2018 Q4	$956M	Buy	41,489,142 +2,155,800	+5%	+$47.9M	1.05%	3
2018 Q3	$927M	Buy	39,333,342 +1,048,742	+3%	+$25.6M	0.95%	6
2018 Q2	$883M	Buy	38,284,600 +4,102,000	+12%	+$97.5M	0.96%	4
2018 Q1	$842M	Buy	34,182,600 +2,720,200	+9%	+$71.4M	0.92%	4
2017 Q4	$844M	Buy	31,462,400 +2,739,800	+10%	+$69.7M	0.93%	2
2017 Q3	$691M	Buy	28,722,600 +1,654,000	+6%	+$37.4M	0.81%	7
2017 Q2	$580M	Sell	27,068,600 -5,749,800	-18%	-$116M	0.74%	11
2017 Q1	$563M	Buy	32,818,400 +4,926,600	+18%	+$85.8M	0.79%	4
2016 Q4	$500M	Sell	27,891,800 -1,415,200	-5%	-$25.7M	0.79%	3
2016 Q3	$609M	Buy	29,307,000 +3,407,400	+13%	+$84.5M	1.08%	1
2016 Q2	$696M	Buy	25,899,600 +348,200	+1%	+$9.55M	1.33%	1
2016 Q1	$692M	Sell	25,551,400 -246,200	-1%	-$6.6M	1.32%	2
2015 Q4	$749M	Sell	25,797,600 -544,400	-2%	-$15.1M	1.63%	1
2015 Q3	$714M	Sell	26,342,000 -1,832,000	-7%	-$51.9M	1.7%	2
2015 Q2	$771M	Sell	28,174,000 -853,200	-3%	-$24M	1.76%	2
2015 Q1	$775M	Sell	29,027,200 -2,202,000	-7%	-$50.7M	1.65%	2
2014 Q4	$661M	Sell	31,229,200 -983,000	-3%	-$22M	1.6%	2
2014 Q3	$767M	Sell	32,212,200 -1,693,800	-5%	-$39M	2.1%	1
2014 Q2	$783M	Buy	33,906,000 +1,746,400	+5%	+$38.6M	1.83%	2
2014 Q1	$734M	Sell	32,159,600 -477,400	-1%	-$10.2M	1.76%	2
2013 Q4	$603M	Buy	32,637,000 +1,275,000	+4%	+$22.2M	1.44%	2
2013 Q3	$531M	Buy	31,362,000 +3,416,000	+12%	+$57.5M	1.29%	2
2013 Q2	$433M	Buy	+27,946,000	New	+$465M	1.14%	5

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Renaissance Technologies's NVO Position: Q1 2026 in Review

Renaissance Technologies increased its Novo Nordisk (NVO) stake by 6.7% in Q1 2026, buying an estimated $10.1M and bringing the position to 3,397,121 shares worth $125M. The position accounts for 0.2% of the portfolio, ranked #108.

Renaissance Technologies first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.14B in Q4 2021. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Renaissance Technologies held 3,397,121 shares of Novo Nordisk worth $125M as of Q1 2026.
Renaissance Technologies bought 213,443 Novo Nordisk shares in Q1 2026, an estimated $10.1M.
Novo Nordisk made up 0.2% of Renaissance Technologies's portfolio in Q1 2026, its #108 holding.
Renaissance Technologies first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
Renaissance Technologies's Novo Nordisk position peaked at $2.14B in Q4 2021.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.